[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
November 27, 2000

Panax (Ginseng) Is Not a Panacea

Arch Intern Med. 2000;160(21):3329. doi:

I read with interest the report by Vuksan et al1 on the effects of American ginseng in subjects both with and without diabetes. The authors cautioned that, because American ginseng attenuated postprandial glycemia in both study groups, it should be taken with meals to prevent unintended hypoglycemia in subjects without diabetes. But there is another important clinical implication of their finding that needs emphasis, ie, potentially serious consequences of drug interactions between American ginseng and other hypoglycemic drugs. For patients with diabetes being treated with either insulin or oral hypoglycemic agents, concurrent use of American ginseng, whether intended or unintended, may precipitate or aggravate a hypoglycemic reaction.

First Page Preview View Large
First page PDF preview
First page PDF preview